Xenon Inhalation for Expeditions to High Altitude: A Position Statement from the International Climbing and Mountaineering Federation (Union Internationale des Associations d'Alpinisme, UIAA) Medical Commission

Kód výsledku v IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00064211%3A_____%2F25%3AW0000083" target="_blank" >RIV/00064211:_____/25:W0000083 - isvavai.cz</a>

Nalezeny alternativní kódy

RIV/68407700:21460/25:00390741 RIV/00216208:11120/25:43928636

Výsledek na webu

<a href="https://oadoi.org/10.1089/ham.2025.0018" target="_blank" >https://oadoi.org/10.1089/ham.2025.0018</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.1089/ham.2025.0018" target="_blank" >10.1089/ham.2025.0018</a>

Jazyk výsledku

angličtina

Název v původním jazyce

Xenon Inhalation for Expeditions to High Altitude: A Position Statement from the International Climbing and Mountaineering Federation (Union Internationale des Associations d'Alpinisme, UIAA) Medical Commission

Popis výsledku v původním jazyce

Hilty, Matthias P, Urs Hefti, Pierre Bouzat, Hannes Gatterer, Lenka Horakova, Linda E Keyes, Justin Lawley, Benjamin D Levine, George Rodway, Daniel Trevena, Eduardo Vinhaes, and Benoit Champigneulle. Xenon Inhalation for Expeditions to High Altitude: A Position Statement from the International Climbing and Mountaineering Federation (Union Internationale des Associations d'Alpinisme, UIAA) Medical Commission. High Alt Med Biol. 00:00-00, 2025.Background and Methods: Recently, xenon inhalation has been advertised for use as a pre-acclimatization method for high-altitude climbs, but this use is controversial and not without risks. The International Climbing and Mountaineering Federation (Union Internationale des Associations d'Alpinisme, UIAA) Medical Commission convened a panel, including external experts, to develop a position statement on xenon inhalation as a pre-acclimatization method.Results: In this statement, we summarize the current state of research and discuss possible directions of future investigations. A pre-acclimatization strategy using xenon inhalation includes risks of respiratory depression, hypoxemia, systemic hypertension, and neurological impairment. The potential benefits of xenon inhalation, such as erythropoiesis, an increase in hemoglobin mass, or increased oxygen availability to the tissues, are not supported by the existing, current evidence.Conclusion: The UIAA Medical Commission recommends against the use of xenon inhalation in preparation for or during expeditions to high altitude unless part of a controlled study with appropriately qualified medical support such as anesthesia personnel.

Název v anglickém jazyce

Xenon Inhalation for Expeditions to High Altitude: A Position Statement from the International Climbing and Mountaineering Federation (Union Internationale des Associations d'Alpinisme, UIAA) Medical Commission

Popis výsledku anglicky

Hilty, Matthias P, Urs Hefti, Pierre Bouzat, Hannes Gatterer, Lenka Horakova, Linda E Keyes, Justin Lawley, Benjamin D Levine, George Rodway, Daniel Trevena, Eduardo Vinhaes, and Benoit Champigneulle. Xenon Inhalation for Expeditions to High Altitude: A Position Statement from the International Climbing and Mountaineering Federation (Union Internationale des Associations d'Alpinisme, UIAA) Medical Commission. High Alt Med Biol. 00:00-00, 2025.Background and Methods: Recently, xenon inhalation has been advertised for use as a pre-acclimatization method for high-altitude climbs, but this use is controversial and not without risks. The International Climbing and Mountaineering Federation (Union Internationale des Associations d'Alpinisme, UIAA) Medical Commission convened a panel, including external experts, to develop a position statement on xenon inhalation as a pre-acclimatization method.Results: In this statement, we summarize the current state of research and discuss possible directions of future investigations. A pre-acclimatization strategy using xenon inhalation includes risks of respiratory depression, hypoxemia, systemic hypertension, and neurological impairment. The potential benefits of xenon inhalation, such as erythropoiesis, an increase in hemoglobin mass, or increased oxygen availability to the tissues, are not supported by the existing, current evidence.Conclusion: The UIAA Medical Commission recommends against the use of xenon inhalation in preparation for or during expeditions to high altitude unless part of a controlled study with appropriately qualified medical support such as anesthesia personnel.

Druh

J_imp - Článek v periodiku v databázi Web of Science

CEP obor

—

OECD FORD obor

30306 - Sport and fitness sciences

Projekt

—

Návaznosti

I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Rok uplatnění

2025

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Název periodika

HIGH ALTITUDE MEDICINE & BIOLOGY

ISSN

1527-0297

e-ISSN

1557-8682

Svazek periodika

26

Číslo periodika v rámci svazku

4

Stát vydavatele periodika

US - Spojené státy americké

Počet stran výsledku

3

Strana od-do

385-387

Kód UT WoS článku

001523355900001

EID výsledku v databázi Scopus

—